Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Financing Diagnostic Imaging Digital Health

Handheld Ultrasound Developer Exo Raised $220M In Series C

  • News

Executive Summary

As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date. 

You may also be interested in...



Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.

GE Healthcare Makes Entry Into Handheld Ultrasound Device Ring

GE Healthcare has announced the launch of Vscan Air, its first wireless ultrasound device.

Ultrasound Market To Bounce Back In 2021; Pandemic Will Accelerate Adoption Of New Tech

Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.

Table

View full table

Topics

Related Companies

Tags:
Financing Diagnostic Imaging Digital Health
UsernamePublicRestriction

Register

MT144290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By